PTPN11 and pulmonary fibrosis: In conclusion, we provide for the first time in the context of lung fibrosis, strong in vitro evidence that SHP2 exerts its anti-fibrotic properties through negative regulation of mitochondrial metabolism and induction of mitophagy through mechanisms that involve interaction with metabolic kinase-controlled signal transduction pathways.